"182" Pill Images
The following drug pill images match your search criteria.
![Pill 1328 Yellow Capsule/Oblong is Amlodipine Besylate, Hydrochlorothiazide and Valsartan](https://www.drugs.com/images/pills/custom/pill23254-1/amlodipine-besylate-hydrochlorothiazide-and-valsartan.jpg)
1328
Amlodipine Besylate, Hydrochlorothiazide and Valsartan
- Strength
- 10 mg / 25 mg / 160 mg
- Imprint
- 1328
- Color
- Yellow
- Shape
- Capsule/Oblong
![Pill WPI 3293 White Capsule/Oblong is Telmisartan](https://www.drugs.com/images/pills/mmx/t111984f/telmisartan.jpg)
1 / 2
Loading
WPI 3293
![Pill BL 323 White Oval is Relcof IR](/img/pillid/no-image-placeholder.png)
BL 323
Relcof IR
- Strength
- guaifenesin 380 mg / phenylephrine hydrochloride 10 mg
- Imprint
- BL 323
- Color
- White
- Shape
- Oval
![Pill SEARLE 2752 NORPACE 100 MG Orange & White Capsule/Oblong is Disopyramide Phosphate](https://www.drugs.com/images/pills/custom/pill29245-1/disopyramide-phosphate.png)
SEARLE 2752 NORPACE 100 MG
Disopyramide Phosphate
- Strength
- 100 mg
- Imprint
- SEARLE 2752 NORPACE 100 MG
- Color
- Orange & White
- Shape
- Capsule/Oblong
![Pill SEARLE 2762 NORPACE 150 MG Brown & Orange Capsule/Oblong is Disopyramide Phosphate](https://www.drugs.com/images/pills/custom/pill29246-1/disopyramide-phosphate.png)
SEARLE 2762 NORPACE 150 MG
Disopyramide Phosphate
- Strength
- 150 mg
- Imprint
- SEARLE 2762 NORPACE 150 MG
- Color
- Brown & Orange
- Shape
- Capsule/Oblong
![Pill 132 BOCA White Oval is Guaifenesin and Pseudoephedrine Hydrochloride SR](/img/pillid/no-image-placeholder.png)
132 BOCA
Guaifenesin and Pseudoephedrine Hydrochloride SR
- Strength
- 1200 mg / 50 mg
- Imprint
- 132 BOCA
- Color
- White
- Shape
- Oval
![Pill L82 Blue & Yellow Capsule/Oblong is Fenofibric Acid Delayed-Release](https://www.drugs.com/images/pills/custom/pill36047-1/fenofibric-acid-delayed-release.png)
L82
Fenofibric Acid Delayed-Release
- Strength
- 135 mg
- Imprint
- L82
- Color
- Blue & Yellow
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.